SWI Editorial Staff2025-10-10T04:43:48-07:00Qualcomm faces antitrust probe in China By Investing.comSWI Editorial Staff2025-10-10T04:43:48-07:00October 10, 2025|
SWI Editorial Staff2025-10-10T04:43:31-07:00Analyst Endorsements and Fund Activity Might Change The Case For Investing In Colgate-PalmSWI Editorial Staff2025-10-10T04:43:31-07:00October 10, 2025|
SWI Editorial Staff2025-10-10T04:43:14-07:00HSBC upgrades Synchrony Financial stock to Buy on capital returnsSWI Editorial Staff2025-10-10T04:43:14-07:00October 10, 2025|
SWI Editorial Staff2025-10-10T04:42:55-07:00OceanFirst Financial stock rating upgraded by KBW on earnings inflection By Investing.comSWI Editorial Staff2025-10-10T04:42:55-07:00October 10, 2025|
SWI Editorial Staff2025-10-10T04:42:39-07:00Jefferies initiates Gyre Therapeutics stock with Buy rating, $16 target By Investing.comSWI Editorial Staff2025-10-10T04:42:39-07:00October 10, 2025|
SWI Editorial Staff2025-10-10T04:42:20-07:00How Recent Developments Are Shaping the Dow Investment StorySWI Editorial Staff2025-10-10T04:42:20-07:00October 10, 2025|
